Coinnect EASM Platform vs ImmuniWeb® Discovery: Side-by-Side Comparison (2026)

Coinnect EASM Platform: EASM platform for continuous external attack surface discovery and risk mgmt. built by Coinnect. Core capabilities include Continuous attack surface monitoring with real-time visibility, AI-driven risk insights using machine learning and predictive analytics, Dark web monitoring for compromised credentials and exposed data..

ImmuniWeb® Discovery: ImmuniWeb Discovery is an attack surface management platform that continuously monitors an organization's external digital assets for security vulnerabilities, misconfigurations, and threats across domains, applications, cloud resources, and the dark web. built by ImmuniWeb. Core capabilities include Attack Surface Management, Continuous Security Monitoring, Third-Party Risk Monitoring..

Both serve the External Attack Surface Management market but differ in approach, feature depth, and target audience.

Both tools share capabilities in third-party risk monitoring. Coinnect EASM Platform differentiates with Continuous attack surface monitoring with real-time visibility, AI-driven risk insights using machine learning and predictive analytics, Dark web monitoring for compromised credentials and exposed data. ImmuniWeb® Discovery differentiates with Attack Surface Management, Continuous Security Monitoring, Cyber Threat Intelligence.

Coinnect EASM Platform is developed by Coinnect. ImmuniWeb® Discovery is developed by ImmuniWeb. Vendor maturity, funding stage, and team size can be important factors when evaluating long-term viability and support quality.

Coinnect EASM Platform and ImmuniWeb® Discovery serve similar External Attack Surface Management use cases: both are External Attack Surface Management tools, both cover Dark Web Monitoring. Review the feature comparison above to determine which fits your requirements.